Concepedia

Darryle D. Schoepp

DD

17

Publications

1.2K

Citations

15

H-Index

1988

Active since

Affiliations

Eli Lilly (United States)(Current)

Darryle D. Schoepp is an author at Eli Lilly (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top concepts

Publications per year

1988–2000

17

Publications

17

The Metabotropic Glutamate 2/3 Receptor Agonists LY354740 and LY379268 Selectively Attenuate Phencyclidine versus d-Amphetamine Motor Behaviors in Rats

Jayne Cartmell, James A. Monn, Darryle D. Schoepp · Journal of Pharmacology and Experimental Therapeutics · 1999 · 268 citations

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

Giuseppe Battaglia, James A. Monn, Darryle D. Schoepp · Neuroscience Letters · 1997 · 163 citations

, , +12

Inhibition of Excitatory Amino Acid‐Stimulated Phosphoinositide Hydrolysis in the Neonatal Rat Hippocampus by 2‐Amino‐3‐Phosphonopropionate

Darryle D. Schoepp, Bryan G. Johnson · Journal of Neurochemistry · 1989 · 114 citations

The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury

John W. McDonald, Darryle D. Schoepp · European Journal of Pharmacology · 1992 · 103 citations

, , +12

The mGlu2/3 receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing

Jayne Cartmell, James A. Monn, Darryle D. Schoepp · European Journal of Pharmacology · 2000 · 90 citations

, , +8

Rows per page

1–5 of 17